Pluri Inc. Prepaid Expense and Other Assets, Current
Pluri Inc. (PLUR) had Prepaid Expense and Other Assets, Current of $810.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-09-10
- 2026-06-30: Prepaid Expense and Other Assets, Current $810.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $816.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $929.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.14M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $810.00K 10-K · filed 2026-09-10 | |
| 2026-03-31 | $816.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $929.00K 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $1.14M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $824.00K 10-K · filed 2026-09-10 | |
| 2025-03-31 | $597.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $656.00K 10-Q · filed 2025-02-11 | |
| 2024-09-30 | $1.01M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $834.00K 10-K · filed 2025-09-17 | $868.00K 10-K · filed 2024-09-18 |
| 2024-03-31 | $1.09M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.26M 10-Q · filed 2024-02-12 | |
| 2023-09-30 | $1.35M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $969.00K 10-K · filed 2024-09-18 | |
| 2023-03-31 | $2.25M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.14M 10-Q · filed 2023-02-13 | |
| 2022-09-30 | $1.05M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.72M 10-K · filed 2023-09-12 | |
| 2022-03-31 | $1.86M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.76M 10-Q · filed 2022-02-07 | |
| 2021-09-30 | $1.55M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $1.82M 10-K · filed 2022-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |